The short version. Bioenergy is an industry: turning biomass, biogas, and biofuels into usable power, heat, or transport fuel through combustion, fermentation, or thermochemical conversion. Bioenergetics is a field of biology: how living cells produce, store, and use energy — and, in engineering practice, the precision thermal management that keeps bioreactors running inside a narrow temperature window. Two different product propositions for MicroPower, two different review panels, two different customer conversations.
Why we insist on the distinction
Federal and European funding programmes use these words precisely. The U.S. Department of Energy's Bioenergy Technologies Office (BETO) scopes to biomass-to-fuel and biomass-to-power research. The National Institutes of Health's biotechnology programmes and the new federal biomanufacturing initiatives scope to living-cell engineering and the thermal-control problems that come with it. If a pitch uses the wrong term, the wrong panel reads it, and the review goes sideways before the technology is even assessed.
Investor audiences do the same thing, informally. A bioenergy investor hears "we recover exhaust heat from biogas engines" and engages on CHP economics, engine displacement, and the sub-1 MW tier where Organic Rankine Cycle turbines stop being economic. A synbio or biomanufacturing investor hears "we provide solid-state cooling for bioreactors" and engages on contamination risk, validation burden, and precision fermentation economics. Same company, same physics, two different conversations.
Bioenergy — the combustion side
Bioenergy is the commercial sector that turns biological feedstocks into energy. It has three sub-segments, and each generates waste heat that is currently vented or dumped into cooling loops:
Biogas. Anaerobic digestion converts agricultural waste, sewage, food waste, or manure into a methane-rich gas. Europe operates more than 20,000 biogas plants. Most burn the biogas on-site in reciprocating engines (Jenbacher, MWM, Caterpillar) to produce combined heat and power. Exhaust leaves those engines at roughly 450–550°C, carrying a meaningful share of the fuel energy as unrecovered heat.
Biomass combustion. Wood chips, pellets, agricultural residues, and black liquor burn in boilers and industrial furnaces to produce heat or steam. Conventional biomass boilers run 25–40% efficient. Exhaust-stack losses are persistent.
Thermochemical and fermentation pathways to fuels. Pyrolysis, gasification, and bio-fermentation routes convert feedstock into bio-oil, syngas, bioethanol, biodiesel, bio-methanol, or bio-jet fuel. All of these are heat-intensive processes; all generate high-grade heat streams somewhere in the cycle.
MicroPower's thermoelectric modules fit on the exhaust side of these processes — typically PowerRing-form modules clamped onto engine exhausts or ducted off boiler stacks. The target is the tier below what Organic Rankine Cycle turbines serve economically, roughly 0.1–1 MW thermal, where ORC capex and complexity overwhelm the recoverable power. It is a complementary layer, not a replacement for ORC where ORC is already economic. The framing, and the honest modelled uplift range (system-level 7–10%, not module-level 14%), live on our Bioenergy & Biogas focus page and in white paper WP-C.
Bioenergetics — the living-systems side
Bioenergetics, in its original sense, is the branch of biochemistry that studies how cells generate ATP, how mitochondria extract energy from food, and how organisms balance the thermodynamic books to stay alive. That is upstream academic context. The engineering translation is this: if you are running a biomanufacturing facility — a pharmaceutical fermenter, a precision-fermentation tank making alt-proteins or speciality ingredients, an algae cultivation system, a bioreactor for gene therapy vectors — then keeping living cells inside a narrow thermal window is the operational core of your process.
Mesophilic fermentation runs around 35–40°C. Thermophilic fermentation runs 50–55°C. Pharmaceutical mammalian-cell bioreactors typically target 37°C with tight tolerance. Step outside the window, productivity collapses. The cells themselves generate metabolic heat; the facility must remove it continuously. In current practice, that removal relies on mechanical chillers, cooling towers, and refrigerant-handling infrastructure that together consume 15–30% of the facility's total electrical load and introduce validation burden, refrigerant-leak risk, vibration, and contamination pathways.
MicroPower's thermoelectric platform is dual-mode — the same physics that generates electricity from a hot side can also pump heat away from a cold side, driven by electrical current. Solid-state, no refrigerant, no moving parts, electronically controllable at fine spatial and temporal resolution. Those properties map well to bioreactor constraints. The honest framing is that bioreactor-scale thermoelectric cooling is lab-demonstrated, not yet commercially deployed — a single 2015 ACS paper on E. coli cultivation is the strongest published reference point. This is a partnership invitation, not a sale. That framing, and the structured-R&D engagement model, live on our Bioenergetics & Synbio focus page and in white paper WP-F.
How the two come together for MicroPower
Same underlying materials platform. Different product propositions, different revenue models, different partners.
On the bioenergy side, MicroPower is selling exhaust-heat recovery equipment on the PowerRing form factor to biogas engine operators, biomass CHP operators, and pyrolysis integrators — a direct product transaction. On the bioenergetics side, MicroPower is offering a solid-state thermal-management R&D capability to bioprocess equipment companies and biomanufacturing operators — a partnership transaction, structured around joint development work and access to a patented dual-mode platform that does not yet have a bioreactor-scale commercial precedent.
Conflating the two costs credibility in both directions. A bioenergy reviewer who hears "living-cell thermal management" thinks the pitch has drifted off brief. A biomanufacturing reviewer who hears "14% conversion efficiency on biogas exhaust" thinks the pitch is about somebody else's product. Keeping the words separate keeps each conversation on-topic.
Where to go next
For the combustion-side product: Bioenergy & Biogas focus page and WP-C — Sub-1 MW Biogas CHP Exhaust Recovery.
For the living-systems-side partnership invitation: Bioenergetics & Synbio focus page and WP-F — Bioreactor Precision Thermal Management.
Or contact us to route your enquiry to the right conversation directly.